Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001601830-25-000035
Filing Date
2025-02-28
Accepted
2025-02-28 06:33:59
Documents
199
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rxrx-20241231.htm   iXBRL 10-K 2764555
2 EX-1.91 exhibit191-insidertradingp.htm EX-1.91 100499
3 EX-4.2 exhibit42-descriptionofsec.htm EX-4.2 39574
4 EX-4.48 exhibit48-globalaccesscomm.htm EX-4.48 185183
5 EX-5.1 exhibit51-wsgropinionfebru.htm EX-5.1 12740
6 EX-10.14 exhibit1014-tayloragreement.htm EX-10.14 74696
7 EX-10.18 exhibit1018-tmarriottsepar.htm EX-10.18 133494
8 EX-10.20 exhibit1020-msecoraseparat.htm EX-10.20 120890
9 EX-10.35 exhibit1035-sanofiagreement.htm EX-10.35 135051
10 EX-10.36 exhibit1036-merckxcollabor.htm EX-10.36 440897
11 EX-10.39 exhibit1039-atmxsalesagree.htm EX-10.39 294454
12 EX-21.1 exhibit211-subsidiarylist.htm EX-21.1 10684
13 EX-23.1 exhibit231-eyconsent.htm EX-23.1 6608
14 EX-23.2 exhibit232-pwcconsent.htm EX-23.2 2322
15 EX-31.1 exhibit311-10xk24.htm EX-31.1 7154
16 EX-31.2 exhibit312-10xk24.htm EX-31.2 7130
17 EX-32.1 exhibit321-10xk24.htm EX-32.1 3352
23 image_0.jpg GRAPHIC 58513
24 image_0a.jpg GRAPHIC 68634
25 image_1.jpg GRAPHIC 37132
26 rxrx-20241231_g1.jpg GRAPHIC 1448276
27 rxrx-20241231_g10.jpg GRAPHIC 621701
28 rxrx-20241231_g11.jpg GRAPHIC 246795
29 rxrx-20241231_g12.jpg GRAPHIC 979391
30 rxrx-20241231_g13.jpg GRAPHIC 583131
31 rxrx-20241231_g14.jpg GRAPHIC 7760947
32 rxrx-20241231_g15.jpg GRAPHIC 289102
33 rxrx-20241231_g16.jpg GRAPHIC 298211
34 rxrx-20241231_g17.jpg GRAPHIC 1198073
35 rxrx-20241231_g18.jpg GRAPHIC 265040
36 rxrx-20241231_g19.jpg GRAPHIC 1084942
37 rxrx-20241231_g2.jpg GRAPHIC 1879718
38 rxrx-20241231_g20.jpg GRAPHIC 732737
39 rxrx-20241231_g21.jpg GRAPHIC 505935
40 rxrx-20241231_g22.jpg GRAPHIC 692420
41 rxrx-20241231_g23.jpg GRAPHIC 737605
42 rxrx-20241231_g24.jpg GRAPHIC 3060830
43 rxrx-20241231_g25.jpg GRAPHIC 1320062
44 rxrx-20241231_g26.jpg GRAPHIC 1108849
45 rxrx-20241231_g27.jpg GRAPHIC 1027756
46 rxrx-20241231_g28.jpg GRAPHIC 1689838
47 rxrx-20241231_g29.jpg GRAPHIC 905720
48 rxrx-20241231_g3.jpg GRAPHIC 3525154
49 rxrx-20241231_g30.jpg GRAPHIC 412293
50 rxrx-20241231_g31.jpg GRAPHIC 2032287
51 rxrx-20241231_g32.jpg GRAPHIC 542417
52 rxrx-20241231_g33.jpg GRAPHIC 728534
53 rxrx-20241231_g34.jpg GRAPHIC 576293
54 rxrx-20241231_g35.jpg GRAPHIC 2079822
55 rxrx-20241231_g36.jpg GRAPHIC 554202
56 rxrx-20241231_g37.jpg GRAPHIC 686900
57 rxrx-20241231_g38.jpg GRAPHIC 774421
58 rxrx-20241231_g39.jpg GRAPHIC 608472
59 rxrx-20241231_g4.jpg GRAPHIC 113264
60 rxrx-20241231_g40.jpg GRAPHIC 580143
61 rxrx-20241231_g41.jpg GRAPHIC 284502
62 rxrx-20241231_g42.jpg GRAPHIC 966461
63 rxrx-20241231_g43.jpg GRAPHIC 785564
64 rxrx-20241231_g44.jpg GRAPHIC 368325
65 rxrx-20241231_g45.jpg GRAPHIC 348208
66 rxrx-20241231_g46.jpg GRAPHIC 308484
67 rxrx-20241231_g47.jpg GRAPHIC 461124
68 rxrx-20241231_g48.jpg GRAPHIC 216434
69 rxrx-20241231_g49.jpg GRAPHIC 464574
70 rxrx-20241231_g5.jpg GRAPHIC 569821
71 rxrx-20241231_g50.jpg GRAPHIC 937270
72 rxrx-20241231_g51.jpg GRAPHIC 550014
73 rxrx-20241231_g52.jpg GRAPHIC 258357
74 rxrx-20241231_g53.jpg GRAPHIC 712019
75 rxrx-20241231_g54.jpg GRAPHIC 555884
76 rxrx-20241231_g55.jpg GRAPHIC 456205
77 rxrx-20241231_g56.jpg GRAPHIC 700855
78 rxrx-20241231_g57.jpg GRAPHIC 651779
79 rxrx-20241231_g58.jpg GRAPHIC 433775
80 rxrx-20241231_g59.jpg GRAPHIC 154560
81 rxrx-20241231_g6.jpg GRAPHIC 3770473
82 rxrx-20241231_g60.jpg GRAPHIC 494898
83 rxrx-20241231_g61.jpg GRAPHIC 849604
84 rxrx-20241231_g62.jpg GRAPHIC 804901
85 rxrx-20241231_g63.jpg GRAPHIC 633841
86 rxrx-20241231_g64.jpg GRAPHIC 349804
87 rxrx-20241231_g65.jpg GRAPHIC 380806
88 rxrx-20241231_g66.jpg GRAPHIC 432942
89 rxrx-20241231_g67.jpg GRAPHIC 3436421
90 rxrx-20241231_g68.jpg GRAPHIC 682996
91 rxrx-20241231_g69.jpg GRAPHIC 310154
92 rxrx-20241231_g7.jpg GRAPHIC 1060717
93 rxrx-20241231_g70.jpg GRAPHIC 895866
94 rxrx-20241231_g71.jpg GRAPHIC 1607253
95 rxrx-20241231_g72.jpg GRAPHIC 1834914
96 rxrx-20241231_g73.jpg GRAPHIC 2935320
97 rxrx-20241231_g74.jpg GRAPHIC 139761
98 rxrx-20241231_g75.jpg GRAPHIC 3543941
99 rxrx-20241231_g76.jpg GRAPHIC 2894765
100 rxrx-20241231_g8.jpg GRAPHIC 291056
101 rxrx-20241231_g9.jpg GRAPHIC 569043
  Complete submission text file 0001601830-25-000035.txt   219395908

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20241231.xsd EX-101.SCH 76655
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20241231_cal.xml EX-101.CAL 133672
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20241231_def.xml EX-101.DEF 396075
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20241231_lab.xml EX-101.LAB 918415
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20241231_pre.xml EX-101.PRE 671442
202 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20241231_htm.xml XML 1404848
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40323 | Film No.: 25682466
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)